Skip to main content
. 2015 Jan 13;16(4):488–493. doi: 10.22074/cellj.2015.494

Fig 2.

Fig 2

Plasma levels of prostate cancer antigen 3 (PCA3) (A) and prostate specific antigen (PSA) mRNA (B), and micro- RNA-141 (miR-141) (C) in prostate cancer (Pca) patients. Total RNA was isolated from plasma, and following cDNA synthesis, each RNA molecule was relatively quantified. Expression levels in healthy individuals were taken as 1 and changes in patients were expressed as 'fold changes'.